Details checkedClinical trial listing onlyCheckedregistry

CMV perilymphatic-fluid diagnostic study during cochlear implantation

Also known as: Collection of sample of perilymphatic fluid during cochlear implantation, CMV perilymphatic fluid study

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Diagnostic

Modality

Biomarker/Specimen Collection

Stage

Not applicable

Status

Unknown

Target Gene

—

Route / Mode

Perilymphatic fluid sample collection during cochlear implantation

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

France

Population

pediatric, cochlear-implant, congenital

Trial IDs

Mechanism

Perilymphatic fluid collection during pediatric cochlear implantation followed by CMV PCR analysis to evaluate congenital CMV involvement in sensorineural hearing loss.

Indications

Hearing Loss Sensorineural Hearing Loss Genetic Hearing Loss

Notes

Registry-verified diagnostic specimen-collection study. It was previously generated as a device-like record, but the intervention is biological sample collection and CMV testing, not a device product.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...

IDs: NCT04724265

Open

Key Events

2020-12-10

CMV perilymphatic-fluid study started

2022-12-10

Estimated completion date listed in registry

Clinical Trials (1)